Copyright Reports & Markets. All rights reserved.

Global Cell Therapy CDMO Services Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cell Therapy CDMO Services by Type
    • 1.3.1 Overview: Global Cell Therapy CDMO Services Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Cell Therapy CDMO Services Consumption Value Market Share by Type in 2024
    • 1.3.3 Preclinical Stage
    • 1.3.4 Clinical Commercialization Stage
  • 1.4 Global Cell Therapy CDMO Services Market by Application
    • 1.4.1 Overview: Global Cell Therapy CDMO Services Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Pharmaceutical Company
    • 1.4.3 Research Institute
  • 1.5 Global Cell Therapy CDMO Services Market Size & Forecast
  • 1.6 Global Cell Therapy CDMO Services Market Size and Forecast by Region
    • 1.6.1 Global Cell Therapy CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Cell Therapy CDMO Services Market Size by Region, (2020-2031)
    • 1.6.3 North America Cell Therapy CDMO Services Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Cell Therapy CDMO Services Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Cell Therapy CDMO Services Market Size and Prospect (2020-2031)
    • 1.6.6 South America Cell Therapy CDMO Services Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Cell Therapy CDMO Services Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Charles River Laboratories
    • 2.1.1 Charles River Laboratories Details
    • 2.1.2 Charles River Laboratories Major Business
    • 2.1.3 Charles River Laboratories Cell Therapy CDMO Services Product and Solutions
    • 2.1.4 Charles River Laboratories Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.2 AGC Biologics
    • 2.2.1 AGC Biologics Details
    • 2.2.2 AGC Biologics Major Business
    • 2.2.3 AGC Biologics Cell Therapy CDMO Services Product and Solutions
    • 2.2.4 AGC Biologics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 AGC Biologics Recent Developments and Future Plans
  • 2.3 FUJIFILM Cellular Dynamics
    • 2.3.1 FUJIFILM Cellular Dynamics Details
    • 2.3.2 FUJIFILM Cellular Dynamics Major Business
    • 2.3.3 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product and Solutions
    • 2.3.4 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 FUJIFILM Cellular Dynamics Recent Developments and Future Plans
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Cell Therapy CDMO Services Product and Solutions
    • 2.4.4 Thermo Fisher Scientific Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.5 Wuxi AppTec
    • 2.5.1 Wuxi AppTec Details
    • 2.5.2 Wuxi AppTec Major Business
    • 2.5.3 Wuxi AppTec Cell Therapy CDMO Services Product and Solutions
    • 2.5.4 Wuxi AppTec Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Wuxi AppTec Recent Developments and Future Plans
  • 2.6 Lonza
    • 2.6.1 Lonza Details
    • 2.6.2 Lonza Major Business
    • 2.6.3 Lonza Cell Therapy CDMO Services Product and Solutions
    • 2.6.4 Lonza Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Lonza Recent Developments and Future Plans
  • 2.7 KBI Biopharma
    • 2.7.1 KBI Biopharma Details
    • 2.7.2 KBI Biopharma Major Business
    • 2.7.3 KBI Biopharma Cell Therapy CDMO Services Product and Solutions
    • 2.7.4 KBI Biopharma Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 KBI Biopharma Recent Developments and Future Plans
  • 2.8 RoslinCT
    • 2.8.1 RoslinCT Details
    • 2.8.2 RoslinCT Major Business
    • 2.8.3 RoslinCT Cell Therapy CDMO Services Product and Solutions
    • 2.8.4 RoslinCT Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 RoslinCT Recent Developments and Future Plans
  • 2.9 Cell and Gene Therapy Catapult
    • 2.9.1 Cell and Gene Therapy Catapult Details
    • 2.9.2 Cell and Gene Therapy Catapult Major Business
    • 2.9.3 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product and Solutions
    • 2.9.4 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Cell and Gene Therapy Catapult Recent Developments and Future Plans
  • 2.10 Cell Therapies
    • 2.10.1 Cell Therapies Details
    • 2.10.2 Cell Therapies Major Business
    • 2.10.3 Cell Therapies Cell Therapy CDMO Services Product and Solutions
    • 2.10.4 Cell Therapies Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Cell Therapies Recent Developments and Future Plans
  • 2.11 Minaris Regenerative Medicine
    • 2.11.1 Minaris Regenerative Medicine Details
    • 2.11.2 Minaris Regenerative Medicine Major Business
    • 2.11.3 Minaris Regenerative Medicine Cell Therapy CDMO Services Product and Solutions
    • 2.11.4 Minaris Regenerative Medicine Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Minaris Regenerative Medicine Recent Developments and Future Plans
  • 2.12 MEDINET
    • 2.12.1 MEDINET Details
    • 2.12.2 MEDINET Major Business
    • 2.12.3 MEDINET Cell Therapy CDMO Services Product and Solutions
    • 2.12.4 MEDINET Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 MEDINET Recent Developments and Future Plans
  • 2.13 Catalent Biologics
    • 2.13.1 Catalent Biologics Details
    • 2.13.2 Catalent Biologics Major Business
    • 2.13.3 Catalent Biologics Cell Therapy CDMO Services Product and Solutions
    • 2.13.4 Catalent Biologics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Catalent Biologics Recent Developments and Future Plans
  • 2.14 Oxford BioMedica
    • 2.14.1 Oxford BioMedica Details
    • 2.14.2 Oxford BioMedica Major Business
    • 2.14.3 Oxford BioMedica Cell Therapy CDMO Services Product and Solutions
    • 2.14.4 Oxford BioMedica Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Oxford BioMedica Recent Developments and Future Plans
  • 2.15 GenScript
    • 2.15.1 GenScript Details
    • 2.15.2 GenScript Major Business
    • 2.15.3 GenScript Cell Therapy CDMO Services Product and Solutions
    • 2.15.4 GenScript Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 GenScript Recent Developments and Future Plans
  • 2.16 Cell-Easy
    • 2.16.1 Cell-Easy Details
    • 2.16.2 Cell-Easy Major Business
    • 2.16.3 Cell-Easy Cell Therapy CDMO Services Product and Solutions
    • 2.16.4 Cell-Easy Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Cell-Easy Recent Developments and Future Plans
  • 2.17 SK pharmteco
    • 2.17.1 SK pharmteco Details
    • 2.17.2 SK pharmteco Major Business
    • 2.17.3 SK pharmteco Cell Therapy CDMO Services Product and Solutions
    • 2.17.4 SK pharmteco Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 SK pharmteco Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cell Therapy CDMO Services Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Cell Therapy CDMO Services by Company Revenue
    • 3.2.2 Top 3 Cell Therapy CDMO Services Players Market Share in 2024
    • 3.2.3 Top 6 Cell Therapy CDMO Services Players Market Share in 2024
  • 3.3 Cell Therapy CDMO Services Market: Overall Company Footprint Analysis
    • 3.3.1 Cell Therapy CDMO Services Market: Region Footprint
    • 3.3.2 Cell Therapy CDMO Services Market: Company Product Type Footprint
    • 3.3.3 Cell Therapy CDMO Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cell Therapy CDMO Services Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Cell Therapy CDMO Services Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Cell Therapy CDMO Services Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Cell Therapy CDMO Services Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Cell Therapy CDMO Services Consumption Value by Type (2020-2031)
  • 6.2 North America Cell Therapy CDMO Services Market Size by Application (2020-2031)
  • 6.3 North America Cell Therapy CDMO Services Market Size by Country
    • 6.3.1 North America Cell Therapy CDMO Services Consumption Value by Country (2020-2031)
    • 6.3.2 United States Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Cell Therapy CDMO Services Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Cell Therapy CDMO Services Consumption Value by Type (2020-2031)
  • 7.2 Europe Cell Therapy CDMO Services Consumption Value by Application (2020-2031)
  • 7.3 Europe Cell Therapy CDMO Services Market Size by Country
    • 7.3.1 Europe Cell Therapy CDMO Services Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 7.3.3 France Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Cell Therapy CDMO Services Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell Therapy CDMO Services Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Cell Therapy CDMO Services Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Cell Therapy CDMO Services Market Size by Region
    • 8.3.1 Asia-Pacific Cell Therapy CDMO Services Consumption Value by Region (2020-2031)
    • 8.3.2 China Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 8.3.5 India Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Cell Therapy CDMO Services Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Cell Therapy CDMO Services Consumption Value by Type (2020-2031)
  • 9.2 South America Cell Therapy CDMO Services Consumption Value by Application (2020-2031)
  • 9.3 South America Cell Therapy CDMO Services Market Size by Country
    • 9.3.1 South America Cell Therapy CDMO Services Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Cell Therapy CDMO Services Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell Therapy CDMO Services Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Cell Therapy CDMO Services Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Cell Therapy CDMO Services Market Size by Country
    • 10.3.1 Middle East & Africa Cell Therapy CDMO Services Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Cell Therapy CDMO Services Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Cell Therapy CDMO Services Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Cell Therapy CDMO Services Market Drivers
  • 11.2 Cell Therapy CDMO Services Market Restraints
  • 11.3 Cell Therapy CDMO Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cell Therapy CDMO Services Industry Chain
  • 12.2 Cell Therapy CDMO Services Upstream Analysis
  • 12.3 Cell Therapy CDMO Services Midstream Analysis
  • 12.4 Cell Therapy CDMO Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cell Therapy CDMO Services market size was valued at US$ 2197 million in 2024 and is forecast to a readjusted size of USD 7339 million by 2031 with a CAGR of 20.5% during review period.
    Cell therapy refers to the transfer of new cells, or cells that have been modified in a laboratory to achieve particular characteristics, into the body to prevent or treat a disease. A Contract Development and Manufacturing Organization (CDMO) is a company that provides comprehensive services to pharmaceutical, biotechnology, and medical device companies. CDMOs offer contract services for product development, formulation, manufacturing, packaging, and distribution. Contract development and manufacturing organizations (CDMOs) play a vital role in cell therapy development by offering crucial infrastructure and expertise.This report mainly focuses on cell therapy CDMO services market.
    The cell therapy CDMO market is mainly concentrated in the following regions: North America (especially the United States) is the leader in the global cell therapy CDMO market, with advanced technology, a sound regulatory system and a large number of biopharmaceutical companies. The active support of the US FDA for cell therapy has also driven the growth of the market in the region. The European market also performed strongly, mainly due to the EU's support for cell therapy research and development and the regulatory framework of the EMA (European Medicines Agency). The United Kingdom, Germany and Switzerland are the main markets in Europe. The Asia-Pacific region (especially China, Japan and South Korea) is one of the fastest growing markets. The Chinese government's policy support and financial investment in the field of cell therapy, as well as Japan's leading position in regenerative medicine, have driven the rapid development of the market in the region. The markets in Latin America and the Middle East are relatively small, but with the popularization of cell therapy technology and the improvement of medical infrastructure, the market potential in these regions is gradually being released.
    Challenges and Opportunities:
    Challenges: The manufacturing process of cell therapy products is complex, requires high quality control, and is expensive. In addition, the instability of the global supply chain and the shortage of raw materials may also affect the delivery of CDMO services. Opportunities: With the advancement of technology and the optimization of manufacturing processes, CDMO companies have the opportunity to further expand their market share by providing efficient and low-cost services. In addition, the rise of emerging markets and the growing demand for personalized medicine have also provided new growth points for CDMO companies.
    This report is a detailed and comprehensive analysis for global Cell Therapy CDMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cell Therapy CDMO Services market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Cell Therapy CDMO Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Cell Therapy CDMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Cell Therapy CDMO Services market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cell Therapy CDMO Services
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cell Therapy CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River Laboratories, AGC Biologics, FUJIFILM Cellular Dynamics, Thermo Fisher Scientific, Wuxi AppTec, Lonza, KBI Biopharma, RoslinCT, Cell and Gene Therapy Catapult, Cell Therapies, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Cell Therapy CDMO Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Preclinical Stage
    Clinical Commercialization Stage
    Market segment by Application
    Pharmaceutical Company
    Research Institute
    Market segment by players, this report covers
    Charles River Laboratories
    AGC Biologics
    FUJIFILM Cellular Dynamics
    Thermo Fisher Scientific
    Wuxi AppTec
    Lonza
    KBI Biopharma
    RoslinCT
    Cell and Gene Therapy Catapult
    Cell Therapies
    Minaris Regenerative Medicine
    MEDINET
    Catalent Biologics
    Oxford BioMedica
    GenScript
    Cell-Easy
    SK pharmteco
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Cell Therapy CDMO Services product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Cell Therapy CDMO Services, with revenue, gross margin, and global market share of Cell Therapy CDMO Services from 2020 to 2025.
    Chapter 3, the Cell Therapy CDMO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cell Therapy CDMO Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Therapy CDMO Services.
    Chapter 13, to describe Cell Therapy CDMO Services research findings and conclusion.

    Buy now